(Nasdaq: ARVN), a clinical-stage biotechnology company creating a ... San Antonio Breast Cancer Symposium (SABCS), taking place December 9–12 ...
News
- Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical ... - BioSpace
- UT Health San Antonio scientists launch innovative therapy study to help Parkinson's ...
SAN ANTONIO, Nov. 24, 2025 – Swallowing difficulties, or dysphagia ... biomedical sciences and public health that are leading change and ...
- CytoDyn to Present Prolonged Survival Data on Leronlimab in Meta - GuruFocus
... Biotechnology CYDY. CytoDyn to Present Prolonged Survival Data on ... San Antonio Breast Cancer Symposium (SABCS), being held December 9-12 ...
- Alliance Mobile Medical Services Launches in San Antonio and DFW - PRWeb
Biotechnology · Clinical Trials & Medical Discoveries · Dentistry · FDA ... San Antonio and the Dallas–Fort Worth Metroplex. The organization ...
- Arvinas to Present Vepdegestrant Data at 2025 SABCS | ARVN Stock News
Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium ( ...